The Frizzled (FZD) 7 receptor (FZD7) is enriched in LGR5 + intestinal stem cells and plays a. com. When expanded it provides a list of search options that will switch the search inputs to match the. D. We cover Rami's new role at Versant, the founding story of. I am a Scientist in the Physiological Chemistry Department of Genentech's research organization. com. and Jim Wells to the portfolio. 2015. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 7 شهر تم التحريرRami Hannoush, Ph. Scheme 1 S2 . ’s Post Rami Hannoush, Ph. Aaron H Nile & Rami N Hannoush* Wnt proteins are critical regulators of signaling networks during embryonic development and in adult tissue homeostasis. Marianne Mertens, Ph. Supplementary Figure 1 S5 . Expand search. … | 79 comments on LinkedInRami Hannoush, Ph. … | 77 comments on LinkedInAt last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Rami Hannoush, Ph. They found a peptide that converts the caspase to its inactive state—the zymogen—and traps it there, a bit like a wheel clamp. Hannoush. One of the toughest things about handing off your bookkeeping is figuring out what to do with all your extra time. 388. D. We cover Rami's new role at Versant, the founding story of. On average, Rami Hannoush works for one company for 2 years 7 months. D. Rami Hannoush, Ph. Supplementary Figure 2 S6 . Rami Hannoush ExploreCourses 2019-2020 2020-2021 2021-2022 2022-2023 2023-2024 Browse by subject. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. 1038/nchembio. degree at McGill University. Hannoush include Harvard University & Scripps Research Institute. 3 Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA 94080; hannoush. 1016/j. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. References [1] J. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 7mo Report this post What are some of the factors that contribute to aging? And could we identify the specific mechanisms by which these factors impair tissue regeneration?Rami Hannoush, Ph. Jennifer Stockdill, Wayne State University. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. D. EpiBiologics Executive Team & Key Decision Makers. Conference Description. D. D. Rami Hannoush, Ph. ’s Post Rami Hannoush, Ph. Patrick Sexton, Monash University. D. This button displays the currently selected search type. Rami Hannoush, Ph. Healthcare VC | Life sciences company creation | Former R&D leader, GenentechTimelines in Drug Development are more important than ever before. Rami Hannoush, Ph. Thrilled to share this work from my former group at Genentech, reporting on a new class of peptide agonists that modulate. D. Healthcare VC | Life sciences company creation. 1038/s41589-018-0035-2 Abstract Regeneration of the adult intestinal epithelium is mediated by a pool of cycling stem cells, which are located at the base of the crypt, that express leucine-rich-repeat-containing. D. Back. D. Rami Hannoush, Ph. . Palmitate can either be added to. The American Peptide Society, APS, a nonprofit scientific and educational organization founded in 1990, provides a forum for advancing and promoting knowledge of the chemistry and biology of peptides. ” Prior to EpiBiologics, Dr. hannoush. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 10mo EditedGreat chat with Ron Leuty from San Francisco Business Times to share our story on building EpiBiologics #companybuilding #degradation | 37 Kommentare auf LinkedInIn an interview with BioPharma Dive: Biotech and Pharma news, our co-founders Jim Wells and Rami Hannoush discussed the company's origin and EpiBiologics' differentiated protein degradation approach. Back Submit. com. Rami Hannoush, Genentech, South San Francisco, USA 5:25 pm General Discussion, Day 2 Wrap-Up 6:00 pm Reception, dinner . D. 05. At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Many proteins have been found to be regulated through S-palmitoylation, a highly conserved process occurring in all eukaryotic organisms that involves the attachment of 16-carbon fatty acids onto cysteine residues via a reversible thioester linkage (Chamberlain and Shipston, 2015, Hannoush, 2015). “Jim and I have known each other for the past 15 years through Genentech collaborations. ’s Post Rami Hannoush, Ph. We are dedicated to bridging ideas from academia with the cutting edge in biotechnology and translation. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. ’s Post Rami Hannoush, Ph. com . He also recently joined Versant Ventures (as a venture partner) where he works on biotech company creation and life science investments. منشور Rami Hannoush, Ph. ⌛ There is a lot of pressure to be able to move from the discovery phase to FIH and…Industry's largest & most renowned event to accelerate your oligo, peptide, mRNA therapeutics to market. Rami Hannoush, Ph. Join to view full profile. com. Rami Hannoush is a co-founder, President and interim CEO of EpiBiologics. Rami Hannoush, Ph. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 7mo Report this post What are some of the factors that contribute to aging? And could we identify the specific mechanisms by which these factors impair tissue regeneration?The image depicts palmitoylated Wnt proteins (rendered from PDB file 4F0A) en route to secretion outside the cell. Chief Operating Officer (650) -. It’s been a terrific two days at #jpm2023, meeting new talent and connecting with friends in pharma and the VC world. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Founded in 2022 and led by CEO Dr. Rami N. Dynasore inhibits cell proliferation of OS in vitro. He brings a unique blend of investment experience and deep drug discovery expertise to our company creation efforts. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. ” Prior to EpiBiologics, Dr. “Dysregulation of normal cellular differentiation processes can alter normal cell biology leading to tumor formation and progression,” said Dr. Inventors: Stefan Dengl, Rami Hannoush, Simon Theodor Hansen, Peter Michael Huelsmann, Robert Franklin Kelley, Hubert Kettenberger, Shrenik Chetan Mehta, Devin Brent Tesar HYALURONIC ACID BINDING DERIVATIVES OF VERSICAN (VG1) FOR LONG ACTING DELIVERY OF THERAPEUTICSRead all stories published by MubadalaVentures in 2022. Rami N. He also served as its founding Chief Scientific Officer and Chair of the Board of Directors since its inception. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Rami Hannoush: Chemical tools to perturb and image Wnt signaling: Danica Galonic Fujimori: 3/15/12: Harmit Malik, Fred Hutchinson Cancer Center: Genetic conflicts: the usual suspects and beyond: John Gross: 4/5/12: Ian Wilson, Scripps: Broad neutralization of HIV and influenza viruses: Bob Stroud:It started with a cup of coffee and a slow burning desire to go early and long in the biotech creation business. Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Dr. Rami. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 6mo Edited Report this post. Rami Hannoush has filed for patents to protect the following inventions. degree at. Back. D. Auron expands its leadership team with the appointments of David Millan, Ph. Published on July 20, 2022. D. Inventors: Eric Bourhis, Tim Cao, Rick Carano, Andrea Cochran, Mike Costa, Venita DeAlmeida, James Ernst, Yan Gong, Rami Hannoush, Paul Polakis, Bonnee Rubinfeld, Mark Solloway, Yan Wu METHODS AND COMPOSITIONS FOR MODULATING THE Wnt PATHWAY Protein palmitoylation plays diverse roles in regulating the trafficking, stability, and activity of cellular proteins. We cover Rami's new role at Versant, the founding story of. D. Read top stories published by MubadalaVentures. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Healthcare VC | Life sciences company creation. ’s Post Rami Hannoush, Ph. Rami Hannoush is the Chief Executive Officer (interim), President and a co-founder of EpiBiologics. Citizen and Immigration Services (USCIS) 2019 Outstanding. Biomarker interview with Rami Hannoush, Ph. cbpa. , 1 DNA Way, South San Francisco, CA 94080, USA. Rami N. … | 79 comments on LinkedInRami Hannoush, Ph. D. D. View Rami Hannosh’s profile on LinkedIn, the world’s largest professional community. Materials availability This study did not generate new unique reagents. ’s Post Rami Hannoush, Ph. . Rami Hannoush, Ph. Patrick Sexton, Monash University. Ribonucleic acids (RNA) are polymers of ribonucleotides linked together by 3',5'-phosphodiester linkages and play a prominent role in protein biosynthesis. Hannoush joined the Early Discovery Biochemistry department at Genentech in 2006 after completing his postdoctoral fellowship at Harvard and his Ph. Xinxin Gao 1and Rami N. Hannoush joined the Early Discovery Biochemistry department at Genentech in 2006 after completing his postdoctoral fellowship at Harvard and his Ph. Copy Link. Hannoush's 87 research works with 3,279 citations and 10,017 reads, including: Synthetic Multivalent Disulfide-Constrained Peptide Agonists Potentiate Wnt1/β-Catenin. We also report a crystal structure of human FZD5 CRD bound to C16:1 cis -Δ9 unsaturated fatty acid. hannoush. Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA, United States. Shawn Zhang Karthik Nagapudi Mike Shen Joshua Lomeo Yuri Qin Aiden Zhu Purnendu Nayak Debby Chang Rami N Hannoush. ’s Post Rami Hannoush, Ph. Jumi Shin, University of Toronto. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. D. D. D. Funds will also. , South San Francisco, California, USA. THE AURON TEAM A CULTURE OF INNOVATION. Eric Shiozaki: Casdin Capital — BrightEdge Fund — Arkin Bio Ventures — Apollo Health Ventures . Thank you Susquehanna University and the…Surrey fellows of the future fellowships: post-doctoral fellowships opportunities leading to a tenured academic position after three years. D. D. References (30) P. BSMB Spring meeting 2022: "Interactions between Lipids/derivatives and the ECM: pre-clinical and clinical relevance" Registration for BSMB members is FREE, £10 and £30 respectively for student. Synthetic therapeutic peptides: science and market. When expanded it provides a list of search options that will switch the search inputs to match the. D. ’s Post Rami Hannoush, Ph. rami@gene. Dr. D. Congrats Juvena Therapeutics for the series A raise. J Pharm Sci 2022 07 10;111(7):1896-1910. Back [email protected] last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Tracking Wnts throughout such processes will present a challenge, but might be facilitated by emerging techniques, such as a method for metabolic labeling of palmitoylated Wnts presented by Rami Hannoush (Genentech, San Francisco, USA) . D. 1073/pnas. , San Francisco, California, USA. 1618293114 Abstract Frizzled (FZD) receptors mediate Wnt signaling in diverse processes ranging from bone growth to stem cell activity. , as Chief Scientific Officer, Thomas Graeber, Ph. H. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 5mo Report this post Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. “We would like to thank Rami Hannoush for his leadership as co-founder and interim CEO and look forward to an exciting next stage of growth for EpiBiologics under Ann’s leadership. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Rami Hannoush, Ph. When expanded it provides a list of search options that will switch the search inputs to match the. Rami Hannoush, Ph. Both structures reveal a dimeric arrangement of the CRD. 9:40 am - 10:05 am: Dinesh Patel (Protagonist Therapeutics Inc. D. Lotte Simonsen, Novo Nordisk. , Partner at Mubadala Capital, and Dr. His current role includes leading interdisciplinary teams in lead discovery and research biology, with the overarching goal of developing therapeutics for the. This button displays the currently selected search type. Joel P. Congrats Cameron! Like Reply 1 Reaction. Currently teaching. Healthcare VC | Life sciences company creation 2yThe 2020 Chemistry and Biology of Peptides Gordon Research Conference will showcase the most recent, cutting edge research in advancing peptides as tools, materials, and therapeutics. He most recently served as a general partner at Mubadala Capital, building the firm's healthcare platform in the. Contact Email [email protected] Abstract Protein palmitoylation plays diverse roles in regulating the trafficking, stability, and activity of cellular proteins. Rami N. , USA) "Challenges and Emerging Approaches in Peptide Drug Discovery" 9:25 am - 9:40 am: Discussion. D. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. Rami Hannoush, PhD. … | 79 comments on LinkedInAt last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Publicação de Rami Hannoush, Ph. D. Rami Hannoush, Ph. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Rami N. Rami Hannoush serves as Venture Partner at Versant Ventures. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. He focuses on early-stage biotechnology investments, and also leads the firm’s efforts in life sciences company creation. D. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. They found a peptide that converts the caspase to its inactive state—the zymogen—and traps it there, a bit like a wheel clamp. D. D. ’s Post Rami Hannoush, Ph. Corresponding author. EpiBiologics Co-Founder. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. Rami N Hannoush Adjunct Professor, Chemical and Systems Biology Operations Print Profile Email Profile Bio Bio Professional Contact. Rami Hannoush, EpiBiologics is building a protein degradation platform that targets membrane and extracellular proteins. Healthcare VC | Life sciences company creation 1yRami Hawash is the owner of a car mechanical repair business in Romford, Essex. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. degree at McGill University. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. CSB 243: Biotechnology and Development of Therapeutics (Autumn) Regeneration of the adult intestinal epithelium is mediated by a pool of cycling stem cells, which are located at the base of the crypt, that express leucine-rich-repeat-containing G-protein-coupled receptor 5 (LGR5). Developing tool ligands that target individual LRP6 domains could help elucidate the mechanism of Wnt signaling regulation and uncover. D. 1038/nchembio. Healthcare VC | Life sciences company creation 1y 2021 Innovative Medicines Fifty new drugs were FDA approved that help improve the health of patients with unmet medical needs. D. Rami Hannoush: Franklin Berger — Eli Lilly — DCVC Bio . Stablix is pioneering an entirely new field of targeted deubiquitination therapeutics (TDT) to bring transformative medicines to patients with unmet medical need. D. ’s Post Rami Hannoush, Ph. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. Beachy. Healthcare VC | Life sciences company creation 6 dComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Back. Schneider, National Cancer Institute – Center for Cancer Research. Rami Hannoush, Ph. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. “Dysregulation of normal cellular differentiation processes can alter normal cell biology leading to tumor formation and progression,” said Dr. Ethics declarations. Rami N. D. Back. Rami N Hannoush 1 Affiliation 1 Department of Early Discovery Biochemistry, Genentech, Inc. 19th Ave New York, NY 95822, USA. Seminar Title: Challenging Targets and Emerging Approaches for Cellular Imaging in the Wnt Pathway, powered by Localist Event Calendar SoftwareRami Hannoush, Ph. She joined Altos at its initiation in 2021 and wasPostdoctoral Research Fellow, Chemical Biology and Biochemistry, Rami Hannoush lab, Genentech Research chez Roche in South San Francisco. View the profiles of professionals named. Rami Hannoush, Ph. Healthcare VC | Life sciences company creation 6dGreat chat with Ron Leuty from San Francisco Business Times to share our story on building EpiBiologics #companybuilding #degradation | 37 comments on LinkedInRami Hannoush, Ph. Rami Hannoush Ph. D. Rami Hannoush, Ph. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Rami Hannoush, PhDPrincipal Scientist & Group Leader at Genentech. ’s Post Rami Hannoush, Ph. Expand search. 1007/978-1-4939-9532-5_17 Abstract Wnts are lipid-modified proteins that regulate stem cell signaling via Frizzled receptors on the cell surface. THE AURON TEAM A CULTURE OF INNOVATION. D. The site facilitates. Biography. … | 77 comments on LinkedInRami Hannoush, Ph. D. ’s Post Rami Hannoush, Ph. D. D. "To our knowledge, no one has identified ligands that bind to the zymogen," said senior author Rami Hannoush, Genentech, South San Francisco, California. The . Aaron H Nile & Rami N Hannoush* Wnt proteins are critical regulators of signaling networks during embryonic development and in adult tissue homeostasis. Aaron H Nile 1 , Susmith Mukund 2 , Karen Stanger 1 , Weiru Wang 2 , Rami N Hannoush 3 Affiliations 1 Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA 94080. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. The design of clickable fatty acid probes is based on the introduction of a small chemical tag (alkyne or azide) at the ω or methyl end of the fatty acid (Figure 2). The lipid-binding groove exhibits flexibility and spans both monomers,. Proud to partner with a great team to systematically explore the untapped therapeutic potential of…“We would like to thank Rami Hannoush for his leadership as co-founder and interim CEO and look forward to an exciting next stage of growth for EpiBiologics under Ann’s leadership. ’s Post Rami Hannoush, Ph. rami@gene. Back. D. … | 79 comments on LinkedInCongratulations to our own Rami Hannoush, Principal Scientist, Early Discovery Biochemistry, for being one of ten to receive the U. Epub 2021 Dec 10. interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures. English. A fascinating approach to degrade membrane proteins/receptors. At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Anwesha Dey,4 Rami N. Rami Hannoush, Ph. 2 From the Department of Early Discovery Biochemistry, Genentech, South San Francisco, California 94080 hannoush. hannoush. CSB 243: Biotechnology and Development of Therapeutics (Autumn)9 Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA, USA. Lipid modification of cellular proteins plays diverse roles in the regulation of such proteins' trafficking, signaling and behavior. … | 79 comments on LinkedInRami Hannoush, Ph. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Auron expands its leadership team with the appointments of David Millan, Ph. Back. 20559317. Three years, 70 Saturdays, 600 hours. Connect Lana Janes, Ph. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 6d EditedRami Hannoush, Ph. ’s Post Rami Hannoush, Ph. EpiBiologics is part of the Business Services industry, and located in California, United States. D. Hannoush ,* 1Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA, USA *Correspondence: hannoush. Rami Hannoush, EpiBiologics is building a protein degradation platform that targets membrane and extracellular proteins. Department of Protein Engineering, Genentech, Inc. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. EpiBiologics's CEO is Rami Hannoush What does EpiBiologics do? Founded in 2022, EpiBiologics is a biotechnology company with a focus on antibody-based protein degradation. 10. D. D General Information. It’s been a terrific two days at #jpm2023, meeting new talent and connecting with friends in pharma and the VC world. View the profiles of professionals named "Rami Hannoush" on LinkedIn. Hannoush, Rami Nabil; Contributors. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Congrats Cameron! Like Reply 1 Reaction. D. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. The authors would like to acknowledge Dr. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. D. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. Back. ”Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. … | 79 تعليقات على LinkedInNatalia Arenas-Ramirez's 3 research works with 164 citations and 145 reads, including: Membrane targeting of palmitoylated Wnt and Hedgehog revealed by chemical probesgeneral partner at GV. Rami N Hannoush, Ph. Mr. D. The author has an hindex of 28, co-authored 68 publications receiving 2989 citations. Lee-Karlon served as Chief Operating Officer of Altos Labs. Expand search. Recent work has focused. D. Rami Hannoush Manage my profile. D. Healthcare VC at Versant | Life sciences company creation | Former R&D leader, Genentech | Former CEO, EpiBiologics 1y. We cover Rami's new role at Versant, the founding story of. ’s Post Rami Hannoush, Ph. Scalable Total Synthesis and Biological Evaluation of Haouamine A and Its Atropisomer. This button displays the currently selected search type. Xinxin Gao, Xinxin Gao. The Wnt Signaling GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. D. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 3mo Edited Report this post At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it provides a blueprint that. Our mission is to partner with visionary founders building enduring technology companies, and support them with Mubadala’s global scale, resources. D. D. President’s Welcome. degree at McGill University. EpiBiologics Co-Founder. Lives in San Mateo, CA. edu - Homepage. ’s Post Rami Hannoush, Ph. D. Search for more papers by this author. D. 05. Adam Catherman for valuable discussions. com. Founded in 2022 and led by CEO Dr. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Related to: Rana Hannoush, 42. EpiBiologics's CEO is Rami Hannoush What does EpiBiologics do? Founded in 2022, EpiBiologics is a biotechnology company with a focus on antibody-based protein degradation. Rami Hannoush, Ph. Founders James Wells, Rami Hannoush. Electronic address: hannoush. D. -based biopharmaceutical company focused on developing therapies that target dysregulated differentiation and cellular. Rami Hannoush, Ph. D. ’s Post Rami Hannoush, Ph. Back.